Detection of the efflux pump-mediated quinolone resistance in ESBL positive Escherichia coli and Klebsiella pneumoniae isolates by Phe-Arg-Beta-naphthylamide;GSBL pozitif Escherichia coli ve Klebsiella pneumoniae İzolatlarında efluks pompası aracılıǧı ile gelişen florokinolon direncinin fenil arginin beta naftilamit ile araştırılması

Turkish Journal of Pharmaceutical Sciences

Volumn 9, Issue 1, 2012, Pages 67-74

  Yedekci, Serhat ^a   Erac, Bayri ^a   Hoşgör Limoncu, Mine ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

E.coli; Efflux; K.pneumoniae; Phe Arg naphthylamide P NA; Quinolone resistance

Indexed keywords

2 NAPHTHYLAMINE; CIPROFLOXACIN; NALIDIXIC ACID; PHENYLARGININE BETA NAPHTHYLAMINE; QUINOLONE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PUMP;

EID: 84859550565     PISSN: 1304530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Heritage J, M'Zali FH, Gascoyne-Birizi D, Hawkoy PM, Evolution and spread of SHV extented-spectrum beta-lactamases in Gram-negative bacteria, J Antimicrob Chemother 44 (3), 309-318, 1999.
2. Sanders WE, Sanders CC, Cycling of antibiotics: an approach to circumvent resistance in specialized units of hospital, Clin Microbiol Infect 1 (4), 223-225, 1996.
3. Cetin BD, Gündüz A, Censoy A, Korkmaz F, Seber E, Hastane infeksiyonu etkeni Gram (-) comaklarda GSBL üretimi ve antibiyotik duyarliliklan, Infeks Derg 16 (4), 463-470, 2002.
4. Balkan II, Gencer S, Batirel A, Özer S, Florokinolonlara karci direnc gelicimine katkida bulunan cesjtli risk faktörlerinin analizi, Flora Derg 10 (2), 65-73, 2005.
5. Bonnet R, Growing group of extended spectrum beta lactamases: The CTX-M enzymes, Antimicrobial Agents Chemother 48 (1), 1-14, 2004.
6. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Epidemiological investigation of fluoroquinolone resistance in infections due to extended spectrum betalactamases producing E. coli and K. pneumoniae, Clin Inf Dis 33 (8), 1288-1294, 2001.
7. Piddock LJ, Mechanisms of fluoroquinolone resistance: an update 1994-1998, Drugs 58(Suppl2), 11-18, 1999.
8. Poole K, Efflux-mediated antimicrobial resistance, J Antimicrob Chemother 56 (1), 20-51, 2005.
9. Yang S, Clayton SR, Zechiedrich EL, Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli, J Antimicrob Chemother 51 (3), 545-556,2003.
10. Pages JM, Amaral L, Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria, Biochim Biophys Acta 1794 (5), 826-833, 2009.
11. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Disc Susceptibility Tests. Fifteenth Informational Supplement. CLSI Document M100-S15. Clinical and Laboratory Standarts Institute, Wayne, Pa, 2005.
12. National Committee for Clinical Laboratory Standards (Clinical and Laboratory Standards Institute). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5 and informational supplement M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2000.
13. Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y, The complete genome sequence of Escherichia coli K-12, Science 277(5331), 1453-1457, 1997.
14. Chung YJ, Saier MHJ, Overexpression of the E.coli sugE gene confers resistance to a narrow range of wuaternary ammonium compounds, J Bacteriol 184 (9), 2543-2545, 2002.
15. Bal C, Toplum kökenli enfeksiyonlarda Gram negatif comak direnci, ANKEM Derg 20 (2), 278-281,2006.
16. Mazzariol A, Tokue Y, Kanegawa MT, Cornaglia G, Nikaido H, High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA, Antimicrob Agents Chemother 44 (12), 3441-3443, 2000.
17. Saenz Y, Ruiz J, Zarazaga M, Teixido M, Torres C, Vila J, Effect of the efflux pump inhibitor Phe-Arg-Beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin, J Antimicrob Chemother 53 (3), 544-545, 2004.
18. Coban AY, Birinci A, Ekinci B, Durupinar B, Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates, Mikrobiyol Bui 38 (1-2), 21-25, 2004.
19. Hasdemir UO, Chevalier J, Nordmann P, Pages JM, Detection and prevalence of active drug efflux mechanism in various multidrug resistant Klebsiella pneumoniae strains from Turkey, J Clin Microbiol 42 (6), 2701-2706, 2004.
20. Tohidpour A, Peerayeh SN, Mehrabadi FJ, Yazdi RH, Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor, CurrMicrob 59 (3), 352-355, 2009.